Clinical implications of serum autotoxin in regular follow up after pediatric living donor liver transplantation for biliary atresia
Author / Expert
Takehisa Ueno, Koki Takase, Chiyoshi Toyama, Koichi Deguchi, Kazunori Masahata, Motonari Nomura, Miho Watanabe, Masafumi Kamiyama, Yuko Tazuke, Kazuhiko Bessho, Hiroomi Okuyama
Topic overview
Abstract
Background
: Pediatric patients sometimes develop graft fibrosis after living donor liver transplant (LDLT). Autotaxin is a recently developed serum marker for hepatic fibrosis. We studied the relationship between serum autotaxin levels and histological findings in patients after LDLT for biliary atresia (BA). Methods: Information on patients aged
Comments